Archive | Drugs

Key Patient Rights Legislation Up Next Week

  Yesterday, the Assembly Health Committee passed one consumer protection measure, SB 923 (Hernandez) on a vote of 17-0, to prevent mid-year increases in co-payments and other cost-sharing by a health plan. Other key legislation also authored by Senate Health Committee Chair Dr. Ed Hernandez and sponsored by Health Access California to protect patients from unfair […]

Continue Reading

Legislative Priorities Clear Deadlines

As the April 22 policy deadline approached, all of Health Access’ priority bills made it over the finish line. Last week, the legislative committees voted on two important bills that will increase transparency in our health care system. Transparency for Prescription Drug Costs Prescription drugs are the health service most commonly used by consumers and […]

Continue Reading

Patient-Protection Bills Moving Forward in Legislature

With the legislative session in full-swing, Health Access California’s bills are moving full steam ahead! Last week, SB 908 and SB 1135 both passed the Senate Health Committee. SB 1135 (Monning) helps consumers know there are time limits on how long they have to wait to get health care appointments and who to complain to if […]

Continue Reading

Covered CA Board Takes Big Steps on Standardized Benefit Design and Quality/Equity Measures; Considers New Barriers to Special Enrollment

Thursday’s Covered California Board meeting, the first since the last day of open enrollment 2013, offered a deep dive on the standardized benefit designs and the quality/equity framework that will guide contracting with insurers for the next 3-year cycle (2017-2019), and a heated discussion about the new documentation requirements that insurers are calling for to qualify […]

Continue Reading
KaiserHealthPrioritiesPickedByPublic_Oct-2015_1000pix

Prescription Costs Transparency Bill Fails in Assembly Health Committee, But Fight Continues

Earlier today the California Assembly Health Committee failed to pass AB 463 (Chiu), a bill introduced last session that would have required greater transparency around the pricing of high-cost medications. Bill author David Chiu pulled the bill because he did not have enough votes, like last year, to get it through committee.  But, as he […]

Continue Reading